Dr. Sandhya R. Nagarakanti, MD

Dr. Nagarakanti practices at Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic.

Dr. Nagarakanti's NPI, 1851510390, was assigned on April 24, 2007. Dr. Nagarakanti graduated from Osmania Medical College NTR UHS in 1999. Dr. Nagarakanti's Arizona license number on file is 67048.

Dr. Nagarakanti's primary practice is Mayo Clinic Hospital - Phoenix, at 5777 East Mayo Boulevard, Phoenix, AZ 85054 in Maricopa County. The practice phone is (480) 342-4201.

Dr. Nagarakanti's primary practice is Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Nagarakanti to 2 more home health agencies and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nagarakanti practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Nagarakanti's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Nagarakanti is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Nagarakanti's licenses on file in 5 states: Arizona, New Jersey, Tennessee, Louisiana and Pennsylvania.

Dmand AI lists hiv/aids, joint or bone infection, pneumonia and UTI among the conditions Dr. Nagarakanti treats.

CMS data shows 440 Medicare services from Dr. Nagarakanti across 5 procedure codes in 2024, for 313 Medicare patients. Medicare paid $46,842 for them.

CMS counts 313 Medicare patients who saw Dr. Nagarakanti in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 3.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nagarakanti's median patient age at 65, with 40% women.

In 2024, Dr. Nagarakanti wrote 315 Medicare Part D claims for 74 patients. 54% of them were for generic drugs. CMS names the drug for 166 of them, across 8 drugs with 11 or more claims each, at $542,146 in total drug cost. In 2023, CMS named 152 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Nagarakanti for performance year 2024, reported as part of a group. Dr. Nagarakanti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nagarakanti as offering telehealth.

Dmand AI links 39 papers to Dr. Nagarakanti, published from 2014 to 2025. 2020 was the busiest year, with 12. The most frequent topics are COVID-19, Antiviral Agents and HIV Infections. Dr. Nagarakanti has published most often in IDCases. Dr. Nagarakanti's most frequent co-authors are Anita Vishram Bapat, MD, Robert Orenstein, DO and Jaspreet Banga.

CMS Open Payments shows 395 general payments to Dr. Nagarakanti from 19 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 52% of the total. ViiV Healthcare Company paid the most, $8,800.

Dr. Nagarakanti graduated from Osmania Medical College NTR UHS in 1999.

Dr. Nagarakanti is in network with 13 carriers, including Aetna, Elevance and Horizon Blue Cross Blue Shield of New Jersey. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.